Release Date: 12/03/15 08:47 Summary: Ensogo to receive an additional $10m new capital Price Sensitive: Yes Download Document 265.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%